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Abstract Verocytotoxin-producing Escherichia coli (VTEC) is recognized as a food-borne pathogen
of major importance. Infection by VTEC is known to cause a wide range of symptoms, from
uncomplicated diarrhoea to haemorrhagic colitis, haemolytic uraemic syndrome and death. VTEC
has primarily been isolated from cattle. However, in several countries VTEC has also been isolated
from pigs. The prevalence in Danish pigs remains unknown but a small-scale study indicated that
is was very low (2.1%) (non-published). All isolates were VTEC types that very rarely have been
associated with human disease and are considered low pathogenic VTEC.
The present risk assessment aimed at assessing whether human cases of VTEC could be at-
tributed to Danish pigs and pork. A review of recent studies on VTEC gave no indication that VTEC
in Danish pork should be considered a risk to the consumers.
Introduction VTEC is an emerging zoonotic pathogen causing severe illness in humans. The main
sources of human exposure to VTEC have been considered to be contaminated bovine products
but several other sources have been identified. At present, pigs and pork are not considered to be
the source of human VTEC infections in Denmark. However, VTEC has been reported in pigs and
pork in several countries and therefore, it cannot be ruled out that pork could be a source of VTEC
infection in humans. 
The present risk assessment was carried out to assess whether human cases of VTEC could
be attributed to Danish pigs and pork.
Materials and Methods The structure in the Codex Alimentarius guideline for risk assessment
was adopted—including hazard identification, hazard characterization, exposure assessment and
risk characterization. 
The hazard identification and characterization covered a description of the agent and its viru-
lence and pathogenicity. A description of the range and severity of clinical manifestations of the
infection in humans was also included. 
In the exposure assessment, both cattle and pigs were considered but the primary focus was
on pigs and pork. The exposure assessment covered: 
< the origin of the meat consumed in Denmark; 
< the prevalence of VTEC in live animals, and in raw meat and meat products in 
several countries; 
< the growth in meat and processed meat and factors influencing it;
< the consumption of meat and meat products in Denmark. 
However, the prevalence data was insufficient and incomplete. Especially, information about
the prevalence of VTEC in Danish pigs and pork was sparse. Data about the consumption of meat
and meat products was also poor, in particular for children below 5 years of age. Considering that
children in this age group appear to be highly susceptible, this constituted a serious problem in
the risk quantification step of the risk characterization. For these reasons, we decided to abandon
the quantitative risk assessment approach and instead carry out a qualitative risk assessment.
Expert opinion was used to increase the applicability of the incomplete data.
Results
Hazard identification VTEC is a food-borne pathogen of major importance. This was realized for
the first time in 1982 in connection with two outbreaks of haemorrhagic colitis (HC) in the states
of Oregon and Michigan, USA (Riley et al., 1983). Since then, several human out-breaks have
been reported throughout the world. 
In Denmark, human cases of VTEC infection have been reported since 1997, when molecular
detection methods were introduced. VTEC is now the 5th most frequent cause of gastrointestinal
infection in humans and more common than Shigella infection (Scheutz et al., 2005). 
Since 1997, there appears to be an increase in the National incidence (3.1 per 100.000 per
year in 2004) (Scheutz et al., 2005) but this may partly be explained by an overall increase in sen-
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sitivity of the diagnostic procedures used. Next to Scotland, Denmark has the highest incidence
of reported human cases of VTEC in Europe (Flemming Scheutz, personal communication, 2005).
Hazard characterization Escherichia coli is a Gram-negative, facultative anaerobic bacterium.
Most of E. coli serotypes are non-pathogenic and an essential part of the normal intestinal flora in
humans and animals. However, certain pathotypes are known to cause gastrointestinal symptoms
in humans and is referred to as diarrhoeagenic E. coli (DEC). DEC can be grouped according to
various virulence factors, including toxin production and adhesion genes. Of these groups only
VTEC is considered to be a zoonotic agent and only VTEC is an occasional finding in pigs. 
Many serotypes of VTEC have been identified. VTEC O157:H7 has most commonly been asso-
ciated with disease in man but other VTEC serotypes are known to cause severe human infec-
tion. Infection by VTEC causes a spectrum of symptoms in humans: from uncomplicated diar-
rhoea to haemorrhagic colitis (HC) and haemolytic uraemic syndrome (HUS) an even death.
Exposure assessment The main sources of human exposure have been contaminated bovine
products such as ground beef, alfalfa sprouts, and raw or improperly pasteurized milk and cheese.
Also beef, sausages (beef and pork) and apple cider have been associated with human cases
(Cassin et al. 1998). Additional sources of exposure have been cross-contamination of ready-to-eat
foods from raw foods or contaminated utensils and by contamination of milk after pasteurization
(Anon., 2004a). Infection may also occur following direct contact with infected animals, person-to-
person transmission, swimming in or drinking contaminated water or eating contaminated fruits
and vegetables (Anon., 2004a). Recent studies have indicated that live animal contact (Jensen et
al., 2004) and person-to-person transmission may be more important than previously assumed
(Scheutz et al., 2003).
There have been 2 outbreaks of VTEC in humans in Denmark—both in 2004. One was as-soci-
ated with a farm visit (Jensen et al., 2004) and one was associated with contaminated cow’s milk
(Mølbak, 2005).
VTEC has been reported in cattle and beef from many countries (Anon., 2004a). The occur-
rence of VTEC in Danish cattle has been monitored since 1997 by bacteriological examination of
faecal samples collected at slaughter. In 2003, VTEC O157 was detected in 7.1% of 212 faecal
samples from slaughter calves (Anon., 2004b). 
Examination of meat and meat products in the retail stage is not part of the routine surveil-
lance but none of the few samples that were examined in 2003 were found positive for VTEC
(Anon., 2004b). 
VTEC has also been isolated from pigs (faeces samples or carcasses) in several countries.
Although the prevalence in most studies is relatively low (<5%) there are also reports of very high
prevalences: 74% in Greece (Anon., 2004a), and 69% in Chile (Borie et al., 1997). The prevalence
of VTEC in the Danish pig herd remains unknown. VTEC is not considered to be a zoonotic prob-
lem in Danish pigs and pork and is therefore not subject to surveillance. However, between 1997
and 1998, the Danish Bacon & Meat Council (DBMC) conducted a small-scale screening (non-pub-
lished). In this study, 40 of 473 faecal samples (8.5%) were found positive in PCR, and 10 of 473
samples (2.1%) were culture positive (Flemming Hansen, personal communication, 2005).
However, it is worth noting that all the culture positive samples were negative for the verocyto-
toxin 2 (vtx2), the E. coli attaching and effacing (eae) gene, the plasmid encoded entero-
haemolysin gene ehxA and plasmid marker for enteroaggregative E. coli (CVD432). Lack of these
virulence factors is indicative of low pathogenic VTEC. 
The prevalence of VTEC O157 in Danish pork was examined in 1996. The 32 regional food con-
trol units placed under the Danish Food and Veterinary Administration conducted a screening for
VTEC in minced meat. A total of 2,112 samples of ground beef and pork were ex-amined for pres-
ence of VTEC O157:H7.  The prevalence in ground beef was 0.1% (2/1584), and the prevalence in
pork was 0.4% (2/528) (Anonymous, 1997). It should be noted, that the VTEC positive samples of
minced pork contained traces of bovine serum protein, which indicated spill-over from grinding of
beef. It was concluded that there had likely been cross-contamination of the pork samples with
VTEC from beef  (Anonymous, 1997).
Denmark imports pork and beef from several countries. The majority of the meat products are
imported from Germany, The Netherlands, UK, Sweden and Spain. (Danish Meat and Bacon
Council, 2005). In 2002, VTEC was found in pigs in The Netherlands (1/3), and in pork in Spain
(5/434=1.2%). VTEC was not detected in pigs in Germany (0/50) nor in Sweden (0/2), and it was
not found in pork in The Netherlands (0/89) nor in Ireland (0/494) (Anon. 2004a).
Risk characterization The present study indicated that there is a low risk that human cases of
VTEC could be attributed to Danish pigs and pork. This is based on the prevalence of culture posi-
tive faecal samples in the DBMS study (2.1%) of which all were of the low pathogenic type.
Moreover, there was a low prevalence of culture positive samples of VTEC O157 in Danish pork
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(0.4%) and it was probably the result of cross-contamination from beef.   
The risk assessment drew attention to the fact that additional or better quality data is needed
about the prevalence and virulence patterns of VTEC in pigs and pork, consumption of meat in
children below 5 years of age, and additional risk factors that may be equally or even more impor-
tant than contaminated food. 
Discussion and Conclusions VTEC can be found in Danish cattle and pigs. However, the preva-
lence in Danish pigs seems to be low. The risk assessment is primarily based on the fact that the
prevalence of VTEC in Danish pigs, as determined in the DBMC study (1997-1998), was low. 
The VTEC isolated from pig faeces appear to be low pathogenic. Ethelberg et al. (2004) stud-
ied the virulence factors for VTEC’s associated with HUS in Denmark, as well as the risk factors
for contracting both HC and HUS. HC and HUS are considered to be the most severe complica-
tions of VTEC infection. The determinants associated with the development of HUS were the vtx2
gene, the eae gene and young age. Considering HC, the determinants found were, again, the
presence of the eae gene and the vtx2 genes, although the vtx2 association was much less pro-
nounced. For this reason, we put much weight on the fact that all the VTEC isolates from pigs in
the DBMC study (1997-1998) were found to be low pathogenic, lacking the important virulence
factors vtx2, eae gene, ehxA and CVD432. 
VTEC is occasionally found in Danish beef and has been found once in Danish pork suspected
to be cross-contaminated from ground beef (Anon., 1997). None of the Danish outbreaks were
related to pigs or pork. 
Apart from the known sources of exposure, infection may also occur following live ruminant
animal contact (Jensen et al., 2004). Therefore, direct contact between children below 5 years of
age, and cattle and small ruminants should be limited and follow certain restrictions and guidelines.
It is essential to provide hygienic food handling, cleaning of utensils such as knives and
grinders and good chilled storage conditions to ensure that other foods do not become contami-
nated (Anon., 2004a).
We acknowledge the fact that more data is required to develop a quantitative risk assess-
ment model to estimate the risk to humans from VTEC in pigs and pork. 
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